Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | BMC Molecular and Cell Biology

Fig. 4

From: Extracellular matrix alterations in the skin of patients affected by psoriasis

Fig. 4

Profile of syndecan-1 (SYND1) in the skin of psoriasis patients compared to control tissue. A, Immunostaining using an anti-syndecan-1 antibody (magnified 400X). B, SYND1 protein expression. The values represent the mean and standard deviation of protein expression of SYND1 obtained by digital quantification (u.o/μm2). C, Messenger RNA (mRNA) expression of syndecan-1 obtained by quantitative RT-PCR. The values represent mean and standard deviation relative to endogenous genes GAPDH (glyceraldehyde-3-fosfate-dehydrogenase) and RPL13a (a ribosomal protein). The values represent the analysis performed in triplicate samples. Control, skin obtained by blepharoplasty; Non-affected, unaltered skin tissue from patient with psoriasis; Psoriasis, affected skin from a central area of the psoriasis plaque

Back to article page

BMC Molecular and Cell Biology

ISSN: 2661-8850

Contact us